BBNX peer analysis
Beta Bionics (BBNX) against its competitors: price, today's move, 1-year return and market value side by side.
BBNX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| DXCM DexCom | $79.45 | -5.93% | 33.99% | $29.62B |
| MMED MiniMed | $16.75 | -7.74% | – | $4.71B |
| MNKD MannKind | $3.85 | 2.39% | -35.73% | $1.25B |
| NVO Novo Nordisk | $40.34 | 0.11% | -16.80% | $136.69B |
| ORMP Oramed | $3.89 | -5.81% | 73.66% | $161.81M |
| PODD Insulet | $146.86 | -5.93% | -53.38% | $10.17B |
| TNDM Tandem Diabetes | $16.91 | -6.00% | 15.27% | $1.18B |
| BBNX Beta Bionics | $15.70 | 1.36% | -40.65% | – |
- BBNX's peers: DXCM (DexCom), MMED (MiniMed), MNKD (MannKind), NVO (Novo Nordisk), ORMP (Oramed), PODD (Insulet), TNDM (Tandem Diabetes).
Updated 2026-11-07 11:56 UTC